AHRQ offers strategies to prevent adverse drug events

AHRQ offers strategies to prevent adverse drug events
Strategies to prevent adverse drug events have been recommended and published in a report by the Agency for Healthcare Research and Quality.

(HealthDay)—Strategies to prevent adverse drug events (ADEs) have been recommended and published in a report by the Agency for Healthcare Research and Quality (AHRQ).

Noting that ADEs account for nearly 700,000 emergency department visits and 100,000 hospitalizations each year, the AHRQ discusses risk factors for ADEs and ways to prevent them.

According to the report, risk factors for ADEs include polypharmacy and limited and numeracy. Elderly and are at elevated risk of ADEs. ADEs can occur as a result of errors in ordering, transcribing, dispensing, or administration of medications, with most ADEs caused by commonly used medications. To prevent ADEs, conservative prescribing principles should be adhered to, and computerized provider order entry and clinical decision support systems should be employed. In addition, medication reconciliation should be implemented at times of transition in care. To eliminate handwriting errors, computerized provider order entry should be used. should oversee the process of medication dispensation. Adherence to the "five rights" of is recommended (right medication, in the right dose, at the right time, by the right route, to the right patient). In addition, barcode medication administration, minimizing , use of smart infusion pumps, and patient education can all help prevent errors at the time of administration.

"Preventing ADEs is a major priority for accrediting and regulatory agencies," the authors write. "The Partnership for Patients has set a goal of reducing preventable ADEs in hospitalized patients by 50 percent by 2013, estimating that more than 800,000 ADEs could be prevented if this goal is met."

More information: More Information

Related Stories

Thousands of patients prescribed high-risk drugs

date Jun 22, 2011

Thousands of patients in Scotland who are particularly vulnerable to adverse drug events (ADEs) were prescribed high-risk medications by their GPs which could potentially cause them harm, according to research published in ...

Med errors common among pediatric cancer outpatients

date Apr 29, 2013

(HealthDay)—Among pediatric cancer patients who receive medications at home, errors are common, with a rate of 3.6 errors with injury per 100 patients, according to a study published online April 29 in ...

Recommended for you

Teva to lift bid for Mylan: report

date Jul 06, 2015

Israeli pharmaceutical giant Teva plans to increase its bid for rival Mylan and could announce the move as soon as this week, according to a US media report Monday.

Vaccine for West Nile Virus enters human clinical trials

date Jul 06, 2015

A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...

FDA clears drug for leading form of cystic fibrosis

date Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.